Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)
NCT01220518
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
257
Enrollment
INDUSTRY
Sponsor class
Conditions
Ankylosing Spondylitis
Interventions
DRUG:
Infliximab
Sponsor
Celltrion